BRIDGE AD 2025

Program Overview

With recent approvals of antiamyloid monoclonal antibodies (mAbs), the field of AD is rapidly changing. Implementation of these therapies requires new protocols and workflows in clinics, including collaboration among multiple departments. This grassroots initiative consists of a 2-part series of live, on-site meetings targeted toward neurology clinicians, radiology clinicians, emergency department staff, and infusion center staff. Drs. Lawrence Honig and David Weisman will discuss details of antiamyloid mAbs, collaboration and communication tips, and best practices for developing implementation protocols. They will also help troubleshoot each location’s protocol development. Participating locations will receive numerous handouts and checklists that will aid in development and implementation of these novel protocols and new workflow procedures. Here, you will have access to an on-demand recording of the live workshops, available for 30 days.